
Apple boss John Ternus reports record sales and profits, but the outlook clouds the mood; Evonik opposes a takeover by BASF.
AI-generated summary
John Ternus succeeded Tim Cook as Apple boss and presented his first quarterly report. Evonik is an Essen-based chemical company that wants to resist a takeover by BASF.
Actually, John Ternus couldn't have wished for a better debut: In his first quarterly report as Apple boss, Tim Cook's successor was able to announce records for sales and profits. In the fourth quarter, which ended at the end of September, Apple's sales rose by twelve percent to $114.5 billion. Analysts had only expected around 113.4 billion. Profit grew 14 percent to $2.10 per share, exceeding forecasts of around $2.
At the same time, expensive memory chips and delivery bottlenecks clouded the outlook. The group only forecast seven to ten percent growth for the Christmas quarter, the most cautious forecast in more than a year. The share lost around three percent after trading. Handelsblatt co-head of the technology team Thomas Jahn explains what investors should know about Apple's situation and Apple's future.
In addition: The Essen-based chemical company Evonik was also able to present good quarterly figures on Tuesday: Adjusted operating profit rose by 40 percent to 629 million euros in the third quarter, and sales rose by 13 percent to 3.8 billion euros.
The presentation of the quarterly figures was also used to send a clear message to competitor BASF, which is interested in a takeover. “We remain fully focused on our strategic direction and our development as an independent company,” said interim CEO Claus Rettig in a conference call with analysts on Tuesday. Handelsblatt industry reporter Isabelle Wermke explains whether the numbers will be enough to keep Evonik independent.
AI outlook — possibilities, not facts
Evonik remains an independent company and is fending off a takeover by BASF.
Possible · Within months

Chancellor Friedrich Merz wants to further reduce the aviation tax in Germany and has confirmed the reversal of the increase planned for July 1st. The aviation industry is calling for taxes and fees to be halved and location costs to be reduced in order to keep flight connections and value creation domestically.

The DAX closed 0.45 percent down at 25,864 points. US midterm elections, oil prices after US air strikes on Iran and quarterly figures from Bayer, Fresenius Medical Care, Zalando and Lufthansa moved the markets.

The retirement savings account will replace the Riester pension from 2027 and offers tax advantages to high earners. Handelsblatt compares it with the net policy and the ETF portfolio and shows who is worth which model for.

BioNTech reports a net profit of 184.5 million euros for the third quarter of 2026, after a loss in the same quarter of the previous year. There is still a loss of 1.17 billion euros for the first nine months. Founders Ugur Sahin and Özlem Türeci are leaving the company by the end of 2026 and moving to the new company Arife in Mainz. Discussions about a possible transfer of BioNTech rights are ongoing, but are optional.

The RAG Foundation, Evonik's major shareholder with 44 percent, is criticized for its investment practices. Insiders accuse her of risky and non-transparent investments, including a credit platform, a Maxburg commitment and an EMH fund. The foundation rejects the allegations and discloses details of the investments.

The AI start-up Anthropic is preparing its IPO. Since private investors cannot purchase shares directly, Handelsblatt analyzes indirect investment opportunities via investment companies, investment funds and synthetic ETPs.